STERIS plc (NYSE:STE), a leader in sterilization and surgical products, has reported a recent transaction by Director Sohi Mohsen, involving the sale of company shares. According to the filing, Mohsen sold a total of 2,037 ordinary shares on May 14, 2024, at prices ranging from $232.96 to $234.04, resulting in a total sale value of over $476,000.
The transaction was part of a series of trades that day, which also included the acquisition of the same number of shares at a price of $51.53 per share. This acquisition is linked to the exercise of stock options that were originally granted before the company redomiciled to Ireland in March 2019. The total value for the acquired shares amounted to approximately $105,000.
Investors tracking insider activity may note that following these transactions, Mohsen's direct ownership in the company adjusted to 22,361 ordinary shares.
STERIS plc, with its headquarters in Dublin, Ireland, operates under the Industrial Applications and Services segment and specializes in a range of orthopedic, prosthetic, and surgical appliances and supplies. The company's stock is publicly traded on the New York Stock Exchange under the ticker symbol STE.
The reported trades were disclosed in compliance with SEC requirements, and the detailed prices for the sales indicate a weighted average, acknowledging that multiple transactions occurred within the specified price ranges. Mohsen has committed to providing full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer, or a security holder of the issuer.
This recent insider trading activity provides investors with up-to-date information on the financial moves of STERIS's executives, which can be a valuable data point for those looking to gauge the company's internal sentiment.
InvestingPro Insights
As investors digest the latest insider trading activity at STERIS plc, real-time data and analysis from InvestingPro can offer additional context. Director Mohsen's recent share sales coincide with some noteworthy metrics and tips that could be of interest to shareholders and potential investors.
InvestingPro data indicates that STERIS plc has a market capitalization of $22.8 billion and is trading at a Price/Earnings (P/E) ratio of 60.21. The adjusted P/E ratio for the last twelve months as of Q4 2024 stands at 37.09, reflecting the company's earnings over that period. Meanwhile, the PEG ratio, which relates the P/E ratio to the company's earnings growth rate, is notably low at 0.16, suggesting that the stock may be undervalued relative to its expected growth.
One of the InvestingPro Tips highlights that STERIS has maintained its dividend payments for 20 consecutive years, a testament to the company's consistent performance and commitment to returning value to shareholders. Additionally, the company has managed to raise its dividend for 13 consecutive years, which could signal confidence in its financial stability and future prospects.
However, it's also important to note that five analysts have revised their earnings expectations downwards for the upcoming period, which may warrant closer attention from investors. Meanwhile, the stock's Relative Strength Index (RSI) suggests it is in overbought territory, potentially indicating a pullback could be on the horizon.
For those interested in a deeper analysis, there are additional InvestingPro Tips available for STERIS plc, which can be accessed at https://www.investing.com/pro/STE. And remember, you can use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription, unlocking even more insights to inform your investment decisions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.